While there are different studies on sodium-glucose co-transporter 2 (SGLT2) inhibitors, there are studies where aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT) and steatosis declined [8]. Here, SLC5A2 is linked to steatosis.